Clinical trial · Observational
Lung Cancer Patients and Parent-child Interaction Experience and Process
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): The number of cases received has reached
Summary
Brief summary (as posted)
Type of study: The goal of this observational study is to explore the relationship between patients with advanced lung cancer and their parent-child interactions during the treatment process, and to understand the impact of the degree of self-differentiation of parents with advanced lung cancer on the physical and mental health of their children. The main questions it aims to answer are: 1. To explore the post-illness adjustment process of patients with advanced lung cancer and the changes in the parent-child relationship among adolescents. 2. To explore the changes in demographic factors-self-belief, mental health, and self-efficacy among patients with advanced lung cancer-and the parent-child relationship among adolescents. 3. Explore the family resilience of patients with advanced lung cancer - family peer relationships, and the interaction between parent-child relationships among adolescents.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer Patients | — | UNRESOLVED | — |
| Parent-child Interaction | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| structured questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Parent-child interaction
- timeFrame
- one years
- description
- The interaction between patients with advanced lung cancer and their parents and children during the treatment process
- measure
- Center for Epidemiological Studies Depression Scale
- timeFrame
- one years
- description
- The CES-D scale is designed to measure an individual's depression level, covering multiple aspects such as depressed mood, guilt, helplessness, decreased appetite, sleep disturbance and psychomotor retardation, with a total of 20 items. The subjects evaluated the frequency of each symptom in the past week using a four-point scale (1 point: never or rarely; 4 points: often). Studies have shown that CES-D has good internal consistency (α=0.85) (Conerly et al., 2002; Given et al., 2004) and reliability (Cronbach's alpha \> 0.85) in cancer patients (Hann et al., 2004). al., 1999) , and therefore can effectively assess the level of depression in cancer patients. In short, the CES-D is a validated tool for assessing depression in cancer patients.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 64 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with advanced lung cancer aged 40 to 64 years (mid-adulthood). 2. There are lung cancer patients in the family who are teenagers aged 10 to 19 years old. 3. Those who voluntarily participate in this study. 4. Voluntary participants can express themselves orally and in handwriting. Exclusion Criteria: 1. Single lung cancer patients over 65 years old. 2. Lung cancer patients under 40 years old. 3. Patients diagnosed with early-stage lung cancer. 4. Those who have cognitive impairment and are unable to understand the problem. 5. Those who are unable to express and respond to questions.
References
Publications (0)
Data not yet available